Stocktoria
Aier Eye Hospital Group Co., Ltd. 300015.SZ
CN · XSHE · XSHE · stock · Healthcare · website
Aier Eye Hospital Group Co., Ltd. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | CN¥22.4B | CN¥21.0B | CN¥20.4B | CN¥16.1B |
| Gross profit | CN¥10.5B | CN¥10.1B | CN¥10.3B | CN¥8.1B |
| R&D expense | CN¥302.5M | CN¥320.6M | CN¥333.5M | CN¥271.7M |
| SG&A expense | CN¥2.1B | CN¥2.1B | CN¥1.9B | CN¥1.6B |
| Operating income | CN¥4.9B | CN¥4.8B | CN¥5.5B | CN¥4.0B |
| Interest expense | CN¥269.7M | CN¥255.6M | CN¥194.8M | CN¥177.6M |
| Income tax | CN¥951.9M | CN¥858.2M | CN¥895.0M | CN¥646.1M |
| Net income | CN¥3.2B | CN¥3.6B | CN¥3.4B | CN¥2.5B |
| EPS (diluted) | CN¥0.35 | CN¥0.38 | CN¥0.36 | CN¥0.28 |
| Operating cash flow | CN¥6.0B | CN¥4.9B | CN¥5.9B | CN¥4.5B |
| Free cash flow | CN¥3.9B | CN¥3.1B | CN¥4.4B | CN¥3.1B |
| Cash & equivalents | CN¥5.3B | CN¥5.4B | CN¥6.1B | CN¥6.0B |
| Inventory | CN¥980.8M | CN¥985.5M | CN¥899.7M | CN¥731.0M |
| Total assets | CN¥36.7B | CN¥33.3B | CN¥30.2B | CN¥26.6B |
| Total liabilities | CN¥13.3B | CN¥11.4B | CN¥10.2B | CN¥9.0B |
| Shareholders' equity | CN¥22.0B | CN¥20.7B | CN¥18.9B | CN¥16.7B |
Growth · year-over-year · Revenue CAGR 11.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +6.5% | +3.0% | +26.4% | — |
| Net income growth | -8.9% | +5.9% | +33.1% | — |
| EPS growth | -9.1% | +5.9% | +30.3% | — |
| Free cash flow growth | +27.1% | -30.8% | +42.2% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · CN · as of 2025-12-31. Figures in CNY. Facts plus Stocktoria's own computed scores — not investment advice.